Ryan Savitz - Sep 11, 2023 Form 3 Insider Report for Dianthus Therapeutics, Inc. /DE/ (MGTA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Adam Veness, as attorney-in-fact for Ryan Savitz
Stock symbol
MGTA
Transactions as of
Sep 11, 2023
Transactions value $
$0
Form type
3
Date filed
9/13/2023, 08:45 PM
Next filing
Jan 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MGTA Stock Option (Right to Buy) Sep 11, 2023 Common Stock 125K $8.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 124,766 shares of the Issuer's common stock, one quarter of which vested on June 2, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney